Clinical trials
Recruiting Cardiovascular Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
213 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 6 |
| 2021 | 10 |
| 2022 | 18 |
| 2023 | 25 |
| 2024 | 39 |
| 2025 | 45 |
| 2026 | 40 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 213 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| VA Office of Research and Development | 8 |
| National Heart, Lung, and Blood Institute (NHLBI) | 7 |
| University of Alabama at Birmingham | 7 |
| Mayo Clinic | 6 |
| The Cleveland Clinic | 6 |
| University of California, San Francisco | 6 |
| Washington University School of Medicine | 5 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 4 |
| University of California, Davis | 4 |
| University of Michigan | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 213 |
| Hypertension | 32 |
| Heart Diseases | 26 |
| Obesity | 23 |
| Heart Failure | 21 |
| Vascular Diseases | 19 |
| Diabetes Mellitus | 16 |
| Diabetes Mellitus, Type 2 | 12 |
| Atherosclerosis | 9 |
| Heart Valve Diseases | 9 |
Trials
Showing 1 to 25 of 213. Each trial links to its page on Pharma Observatory.
113 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.